Navigation Links
Emerald Dairy Extends Terms of Offer for Early Exercise of Warrants
Date:10/31/2008

RESTON, Va., Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- Emerald Dairy Inc. (OTC Bulletin Board: EMDY) announced today that the Company has extended the terms of its offer to existing warrant holders to exercise their warrants on amended terms. The offer to exercise the warrants on amended terms was scheduled to expire on October 31, 2008, but has been extended by the Company until November 21, 2008. If all of the Company's outstanding warrants to purchase approximately 8.0 million shares are exercised according to the amended terms, the Company should receive funds for approximately $16.9 million. To date, two warrant holders have exercised their warrants for 180,000 shares under the amended terms. A number of others have indicated a desire to exercise, but have not provided all of the necessary documentation in order to do so. The Company expects to apply the proceeds from the exercise of warrants toward the cost of constructing a new production facility.

Amended terms, originally offered on April 24, 2008, include the following:

-- With respect to the 373,344 warrants having an exercise price of

$0.94 per share, a holder accepting the offer may exercise some or

all of the warrants at $0.75 per share of Common Stock;

-- With respect to the 1.3 million warrants having an exercise price of

$1.50 per share, a holder accepting the offer may exercise some or all

of the warrants at $1.20 per share of Common Stock;

-- With respect to the 1.4 million warrants having an exercise price of

$2.04 per share, a holder accepting the offer may exercise some or all

of the warrants at $1.63 per share of Common Stock; and

-- With respect to the 4.9 million warrants having an exercise price of

$3.26 per share, a holder accepting the offer may exercise some or all

of the warrants at $2.61 per share of Common Stock.

Warrant holders with questions or concerns regarding the option to exercise warrants should contact the exchange agent for the offer, John Harmann at Computershare, Inc., at 303-262-0775 or 800-962-4284 ext 5732 or by e-mail to: John.Harmann@computershare.com.

About Emerald Dairy Inc.:

Through its wholly-owned operating subsidiaries, Emerald Dairy Inc. is a producer and distributor of infant and children's formula, milk powder and soybean products in the People's Republic of China. The Company's products are sold under two brand names -- "Xing An Ling" and "Yi Bai."

Certain statements in this release and other written or oral statements made by or on behalf of the Company are "forward looking statements" within the meaning of the federal securities laws. Statements regarding future events and developments and our future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. The forward looking statements are subject to a number of risks and uncertainties including market acceptance of the Company's services and projects and the Company's continued access to capital and other risks and uncertainties. The actual results the Company achieves may differ materially from any forward- looking statements due to such risks and uncertainties. These statements are based on our current expectations and speak only as of the date of such statements.

For more information, please contact:

In the U.S.:

Ashley Ammon

ICR, Inc.

Tel: +1-203-682-8200

In China:

Wei-Jung Yang

ICR, Inc.

Tel: +86-10-8523-3088


'/>"/>
SOURCE Emerald Dairy Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
2. The Emerald Dream Ball
3. Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis
4. China-Biotics, Inc. Sees No Impact on Its Business From Dairy Products Safety Concerns
5. PA Agriculture Department Warns Consumers About Raw Milk Sold by York County Dairy
6. National Dairy Council Joins USDA in Partnering With MyPyramid
7. ExploreDairy.com Debuts With Information on Minnesota Dairy Events, People and Products
8. Wildcat Power Cord Repairs Cruciate Ligament in Dairy Cows Knee
9. African Americans at Risk for Low Calcium Intake - New Survey Finds Those Experiencing Symptoms of Lactose Intolerance May be Sidelining Dairy in Their Diets
10. Allergy Alert on Undeclared Soy Ingredient in Bulk Cases of GFS Ultra-Pasteurized Non-Dairy Creamer
11. Low-Fat Dairy Reduces High Blood Pressure Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... In just a short time ... already been receiving positive feedback from customers trying the product for the first time, ... Brain Booster was developed by neurosurgeon Shawn Moore, MD, for everyone from athletes at ...
(Date:9/20/2017)... ... ... The Centers for Medicare and Medicaid Services (CMS) stated in the Inpatient ... Worksheet S-10 to distribute Disproportionate Share Hospital (DSH) Uncompensated Care Payments over the next ... on October 17, 2017 at 2 P.M. EST and uncover how you can prepare ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... feel good program from Leany Greeny delivers positive results in just three weeks. ... health and kickstart the metabolism. Fitting seamlessly into hectic work and family schedules, ...
(Date:9/20/2017)... ... September 20, 2017 , ... “Finn Mouseson”: follows the exciting ... an average life. This mouse sets out on a journey that will show that ... is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, who has earned ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Psalms of ... give peace of mind and move the readers one step closer to God. “Psalms ... has realized that his mistakes that have been made within his life are the ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017 NeuroRx, a clinical ... Suicidal Ideation and Behavior (ASIB), has been granted Fast Track ... sequential therapy of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine ... a pivotal trial of this sequential therapy targeting patients who ... 1 ...
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology: